RIVER STONE USES SYNTHETIC BIOLOGY TO ENABLE NEW PHARMACEUTICAL APPROACHES
Synthetic Biology is disrupting multiple industries.
River Stone is a synthetic biology company with a focus on the novel production of specific small molecule APIs.
Significant advances in the ability to design, build and test biological and biochemical systems over the last two decades has enabled the creation of optimized manufacturing methodology that River Stone has applied to targeted molecules. Associated molecular assemblies and materials are cheaper, processes faster and processes more scalable than ever before.
PIONEERING SYNTHETIC BIOLOGY
River Stone was founded in 2016 with a focus on API production route re-engineering. Our team has a track record in building pioneering synthetic biology and life science ventures. The team has brought multiple synbio and pharma products to market.
Our teams have taken multiple products from idea to commercial launch.
Extensive experience in developing, scaling production methodology, manufacturing and commercializing specialty molecules